Hualan Biological Engineering Inc. Stock Analysis 002007.SZ

Hualan Biological Engineering, Inc. engages in the research, development, production, and sale of self-produced biological and blood products. The company is headquartered in Xinxiang, Henan and currently employs 4,117 full-time employees. The company went IPO on 2004-06-25. The firm's business includes three types of business: research and development and production of blood products, vaccine products, innovative drugs and biosimilars. Among them, blood products include human albumin, intravenous human immunoglobulin, human immunoglobulin, human prothrombin complex, human fibrinogen, rabies human immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin and others.